Sequenta Receives $13,000,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b32a76f5-c068-4778-b05f-4012a8be3f03&Preview=1 -
Date
12/8/2010 -
Company Name
Sequenta -
Mailing Address
409 Illinois St. San Francisco, CA 94158 -
Company Description
Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. -
Website
http://www.sequentainc.com -
Transaction Type
Venture Equity -
Transaction Amount
$13,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The new funds will be used to continue development and commercialization of molecular diagnostic assays based on a proprietary sequencing approach to the profiling T and B cell receptor repertoires. -
M&A Terms
-
Venture Investor
Index Ventures -
Venture Investor
Mohr Davidow Ventures -
Venture Investor
Undisclosed
